Haemonetics Corporation (NYSE:HAE) was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $44.96–$47.88 in the past one-month time frame, witnessed a sharp increase yesterday.
The shares rose after the company reported better-than-expected second quarter and first Half Fiscal 2018 results
The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Haemonetics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Haemonetics Corporation Price and Consensus
Wall Street’s Next Amazon (NASDAQ:AMZN)
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Haemonetics Corporation (HAE): Free Stock Analysis Report
Terumo Corp. (TRUMY): Free Stock Analysis Report
Original post
Zacks Investment Research